Collegium Pharmaceutical Inc expected to post earnings of 90  cents a share - Earnings Preview

Collegium Pharmaceutical

07/05/2022 03:01

* Collegium Pharmaceutical Inc  COLL.OQ   COLL.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 10. 
    * The Stoughton Massachusetts-based  company is expected to
report
 a 10.1% decrease in revenue to $78.884 million from $87.72
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Collegium
Pharmaceutical
Inc is for earnings of 90 cents per share. For the same quarter
last year, the company reported earnings of 41 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $29​, above​ its last closing price
of $14.70. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  1.06        1.04       -0.51     Missed  -149.2
 Sep. 30 2021  0.95        0.95       0.22      Missed  -76.9
 Jun. 30 2021  0.36        0.47       0.27      Missed  -42.8​
 Mar. 31 2021  0.30        0.42       0.41      Missed  -2.8
 ​​Dec.        0.28        0.39       0.20      Missed  -48.5
 31 2020                                                
 Sep. 30 2020  0.23        0.41       0.32      Missed  -21.7​
 Jun. 30 2020  0.18        0.31       0.23      Missed  -24.6
 Mar. 31 2020  0.39        0.41       0.01      Missed  -97.6
 This summary was machine generated May 7 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated